166 related articles for article (PubMed ID: 28219049)
1. The clinical value and biological function of PTTG1 in colorectal cancer.
Ren Q; Jin B
Biomed Pharmacother; 2017 May; 89():108-115. PubMed ID: 28219049
[TBL] [Abstract][Full Text] [Related]
2. Pituitary tumor transforming gene-1 in non-small cell lung cancer: Clinicopathological and immunohistochemical analysis.
Wang F; Liu Y; Chen Y
Biomed Pharmacother; 2016 Dec; 84():1595-1600. PubMed ID: 27829547
[TBL] [Abstract][Full Text] [Related]
3. Pituitary tumor-transforming gene-1 serves as an independent prognostic biomarker for gastric cancer.
Xu MD; Dong L; Qi P; Weng WW; Shen XH; Ni SJ; Huang D; Tan C; Sheng WQ; Zhou XY; Du X
Gastric Cancer; 2016 Jan; 19(1):107-15. PubMed ID: 25627474
[TBL] [Abstract][Full Text] [Related]
4. FoxM1 transactivates PTTG1 and promotes colorectal cancer cell migration and invasion.
Zheng Y; Guo J; Zhou J; Lu J; Chen Q; Zhang C; Qing C; Koeffler HP; Tong Y
BMC Med Genomics; 2015 Aug; 8():49. PubMed ID: 26264222
[TBL] [Abstract][Full Text] [Related]
5. PTTG1 regulated by miR-146a-3p promotes bladder cancer migration, invasion, metastasis and growth.
Xiang W; Wu X; Huang C; Wang M; Zhao X; Luo G; Li Y; Jiang G; Xiao X; Zeng F
Oncotarget; 2017 Jan; 8(1):664-678. PubMed ID: 27893422
[TBL] [Abstract][Full Text] [Related]
6. RNAi-mediated knockdown of pituitary tumor- transforming gene-1 (PTTG1) suppresses the proliferation and invasive potential of PC3 human prostate cancer cells.
Huang SQ; Liao QJ; Wang XW; Xin DQ; Chen SX; Wu QJ; Ye G
Braz J Med Biol Res; 2012 Nov; 45(11):995-1001. PubMed ID: 22872288
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of PTTG1 inhibits the growth and invasion of lung adenocarcinoma cells through regulation of TGFB1/SMAD3 signaling.
Li WH; Chang L; Xia YX; Wang L; Liu YY; Wang YH; Jiang Z; Xiao J; Wang ZR
Int J Immunopathol Pharmacol; 2015 Mar; 28(1):45-52. PubMed ID: 25816405
[TBL] [Abstract][Full Text] [Related]
8. PTTG1 Levels Are Predictive of Saracatinib Sensitivity in Ovarian Cancer Cell Lines.
Nakachi I; Helfrich BA; Spillman MA; Mickler EA; Olson CJ; Rice JL; Coldren CD; Heasley LE; Geraci MW; Stearman RS
Clin Transl Sci; 2016 Dec; 9(6):293-301. PubMed ID: 27766744
[TBL] [Abstract][Full Text] [Related]
9. Pituitary tumor transforming gene 1 promotes proliferation and malignant phenotype in osteosarcoma via NF-κB signaling.
Hu X; Yang F; Mei H
J Orthop Sci; 2024 Jan; 29(1):306-314. PubMed ID: 36414514
[TBL] [Abstract][Full Text] [Related]
10. The PTTG1-targeting miRNAs miR-329, miR-300, miR-381, and miR-655 inhibit pituitary tumor cell tumorigenesis and are involved in a p53/PTTG1 regulation feedback loop.
Liang HQ; Wang RJ; Diao CF; Li JW; Su JL; Zhang S
Oncotarget; 2015 Oct; 6(30):29413-27. PubMed ID: 26320179
[TBL] [Abstract][Full Text] [Related]
11. PTTG1 promotes migration and invasion of human non-small cell lung cancer cells and is modulated by miR-186.
Li H; Yin C; Zhang B; Sun Y; Shi L; Liu N; Liang S; Lu S; Liu Y; Zhang J; Li F; Li W; Liu F; Sun L; Qi Y
Carcinogenesis; 2013 Sep; 34(9):2145-55. PubMed ID: 23671127
[TBL] [Abstract][Full Text] [Related]
12. FAM83D knockdown regulates proliferation, migration and invasion of colorectal cancer through inhibiting FBXW7/Notch-1 signalling pathway.
Mu Y; Zou H; Chen B; Fan Y; Luo S
Biomed Pharmacother; 2017 Jun; 90():548-554. PubMed ID: 28407575
[TBL] [Abstract][Full Text] [Related]
13. MiRNA-494 inhibits metastasis of cervical cancer through Pttg1.
Chen B; Hou Z; Li C; Tong Y
Tumour Biol; 2015 Sep; 36(9):7143-9. PubMed ID: 25877755
[TBL] [Abstract][Full Text] [Related]
14. The long non-coding RNA PTTG3P promotes growth and metastasis of cervical cancer through PTTG1.
Guo XC; Li L; Gao ZH; Zhou HW; Li J; Wang QQ
Aging (Albany NY); 2019 Mar; 11(5):1333-1341. PubMed ID: 30853662
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of SNORA42 as an oncogene and a prognostic biomarker in colorectal cancer.
Okugawa Y; Toiyama Y; Toden S; Mitoma H; Nagasaka T; Tanaka K; Inoue Y; Kusunoki M; Boland CR; Goel A
Gut; 2017 Jan; 66(1):107-117. PubMed ID: 26475630
[TBL] [Abstract][Full Text] [Related]
16. Low Expression of DYRK2 (Dual Specificity Tyrosine Phosphorylation Regulated Kinase 2) Correlates with Poor Prognosis in Colorectal Cancer.
Yan H; Hu K; Wu W; Li Y; Tian H; Chu Z; Koeffler HP; Yin D
PLoS One; 2016; 11(8):e0159954. PubMed ID: 27532268
[TBL] [Abstract][Full Text] [Related]
17. Expression of pituitary-tumour transforming gene in colorectal tumours.
Heaney AP; Singson R; McCabe CJ; Nelson V; Nakashima M; Melmed S
Lancet; 2000 Feb; 355(9205):716-9. PubMed ID: 10703804
[TBL] [Abstract][Full Text] [Related]
18. Decreased expression of SCUBE2 is associated with progression and prognosis in colorectal cancer.
Song Q; Li C; Feng X; Yu A; Tang H; Peng Z; Wang X
Oncol Rep; 2015 Apr; 33(4):1956-64. PubMed ID: 25672935
[TBL] [Abstract][Full Text] [Related]
19. PTTG1 expression is associated with hyperproliferative disease and poor prognosis in multiple myeloma.
Noll JE; Vandyke K; Hewett DR; Mrozik KM; Bala RJ; Williams SA; Kok CH; Zannettino AC
J Hematol Oncol; 2015 Oct; 8():106. PubMed ID: 26445238
[TBL] [Abstract][Full Text] [Related]
20. Solute carrier organic anion transporter family member 4A1 (SLCO4A1) as a prognosis marker of colorectal cancer.
Ban MJ; Ji SH; Lee CK; Bae SB; Kim HJ; Ahn TS; Lee MS; Baek MJ; Jeong D
J Cancer Res Clin Oncol; 2017 Aug; 143(8):1437-1447. PubMed ID: 28378090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
